http://www.advfn.com/nyse/rss.asp?symbol=FRX Forest Labs Company Newsfeed en Tue, 15 Jan 2013 09:05:33 EST Tue, 15 Jan 2013 09:05:33 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=55849306&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=55849306&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Tuesday's session are Express Inc. (EXPR), Gordmans Stores Inc. (GMAN) and QLogic Corp. (QLGC). </p> <p> Express raised its fourth-quarter earnings and comparable sales guidance, citing stronger-than-expected performance... Tue, 15 Jan 2013 09:05:33 EST http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53956717&headline=forest-labs-unveils-shareholder-rights-plan http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53956717&headline=forest-labs-unveils-shareholder-rights-plan <div class='newsbody'><p> Forest Laboratories Inc. (FRX) said its board has adopted a shareholder-rights plan after activist shareholder Carl Icahn recently increased his ownership stake in the company. </p> <p> A rights plan, also known as a poison pill, often is used to thwart potential hostile-takeover... Mon, 27 Aug 2012 18:30:14 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53836388&headline=forest-labs-shareholders-reelect-9-board-members http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53836388&headline=forest-labs-shareholders-reelect-9-board-members <div class='newsbody'><p> NEW YORK--Forest Laboratories Inc. (FRX) shareholders reelected nine of the ten board members nominated by the drug maker, but gave the final slot to a nominee by activist investor Carl Icahn. </p> <p> The pharmaceutical company said preliminary results showed that Mr. Icahn's... Wed, 15 Aug 2012 12:00:17 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53807749&headline=icahn-criticizes-forest-labs-on-fda-warning-letter http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53807749&headline=icahn-criticizes-forest-labs-on-fda-warning-letter <div class='newsbody'><p> Activist investor Carl Icahn criticized Forest Laboratories Inc. (FRX) for failing to disclose its latest warning letter from the U.S. Food and Drug Administration for a violation of promotional practices by the company's sales representatives regarding its drug Daliresp. </p> <p>... Mon, 13 Aug 2012 19:30:30 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53775755&headline=forest-labs-agrees-to-corporate-governance-changes http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53775755&headline=forest-labs-agrees-to-corporate-governance-changes <div class='newsbody'><p> Forest Laboratories Inc. (FRX) has agreed to adopt new corporate-governance measures in a proposed settlement of shareholder lawsuits accusing the drug maker's directors of overpaying long-time leader Howard Solomon and misleading investors about the company's legal troubles... Thu, 09 Aug 2012 16:50:36 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53574479&headline=icahn-sounds-the-alarm-on-forest-labs http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53574479&headline=icahn-sounds-the-alarm-on-forest-labs <div class='newsbody'><p> By Saabira Chaudhuri </p> <p> Carl Icahn has fired back at Forest Laboratories Inc.'s (FRX) board, writing another harshly worded letter despairing the company's prospects, the latest move in a long-running battle between the drug maker and the billionaire investor. </p> <p>... Tue, 24 Jul 2012 10:40:03 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53564004&headline=fda-approves-forest-laboratories-tudorza-pressair http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53564004&headline=fda-approves-forest-laboratories-tudorza-pressair <div class='newsbody'><p> WASHINGTON--The Food and Drug Administration approved Monday a new lung drug designed to treat chronic obstructive pulmonary disease that will be marketed by Forest Laboratories Inc. (FRX). </p> <p> The drug, Tudorza Pressair, is a long-acting medicine that is delivered through... Mon, 23 Jul 2012 17:00:23 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53474147&headline=forest-labs-finds-fault-with-icahn-slate http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53474147&headline=forest-labs-finds-fault-with-icahn-slate <div class='newsbody'><p> Forest Laboratories Inc.'s (FRX) board sent a letter to the drug maker's shareholders criticizing billionaire investor Carl Icahn's slate of four board candidates--the latest in a back-and-forth between the company and the activist shareholder. </p> <p> Mr. Icahn has been in... Mon, 16 Jul 2012 08:30:23 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53309494&headline=correct-applications-given-early-antitrust-clearance http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53309494&headline=correct-applications-given-early-antitrust-clearance <div class='newsbody'><pre> ("Applications Given Early Antitrust Clearance" at 1530 GMT misstated the days when the last two deals on the table cleared.) </pre> <p> The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance... Mon, 09 Jul 2012 12:14:53 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53308589&headline=applications-given-early-antitrust-clearance http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=53308589&headline=applications-given-early-antitrust-clearance <div class='newsbody'><p> The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance from regulators. Requests for early termination or clearance are granted when the Federal Trade Commission and the antitrust division... Mon, 09 Jul 2012 12:01:05 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52974706&headline=icahn-says-chesapeake-can-meet-funding-gap-by-cutting-costs http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52974706&headline=icahn-says-chesapeake-can-meet-funding-gap-by-cutting-costs <div class='newsbody'><p> Activist investor Carl Icahn said that Chesapeake Energy Corp.'s (CHK) assets are undervalued, and the company's worth is likely to rise in coming years as natural gas becomes more prized. </p> <p> In an interview with CNBC, the activist investor, who has recently become troubled... Mon, 02 Jul 2012 21:10:33 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52973790&headline=icahn-chesapeake-can-meet-funding-gap-by-cutting-costs-cnbc http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52973790&headline=icahn-chesapeake-can-meet-funding-gap-by-cutting-costs-cnbc <div class='newsbody'><pre> By Angel Gonzalez </pre> <p> Activist investor Carl Icahn said that Chesapeake Energy Corp.'s (CHK) assets are undervalued, and the company's worth is likely to rise in coming years as natural gas becomes more prized. </p> <p> In an interview with CNBC, the activist investor... Mon, 02 Jul 2012 18:09:12 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52971159&headline=icahn-accuses-forest-labs-ceo-of-500-million-stock-dump http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52971159&headline=icahn-accuses-forest-labs-ceo-of-500-million-stock-dump <div class='newsbody'><p> Carl Icahn accused drug maker Forest Laboratories Inc. (FRX) Chief Executive Howard Solomon of selling more than $500 million of stock ahead of the company's loss of patent exclusivity on antidepressant Lexapro, as the activist investor stepped up his attack on the drug maker's... Mon, 02 Jul 2012 15:30:10 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52820188&headline=icahn-nominates-four-to-forest-laboratories-board http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52820188&headline=icahn-nominates-four-to-forest-laboratories-board <div class='newsbody'><p> Activist investor Carl Icahn has nominated four candidates to Forest Laboratories Inc.'s (FRX) board and is seeking records of the pharmaceutical company board's actions, nearly a year after an effort to gain board seats failed. </p> <p> According to a filing with the Securities... Tue, 19 Jun 2012 15:10:12 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52031686&headline=forest-labs-4q-net-falls-40-as-lexapro-patent-expires-has-upbeat http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=52031686&headline=forest-labs-4q-net-falls-40-as-lexapro-patent-expires-has-upbeat <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Forest Laboratories Inc.'s (FRX) fiscal fourth-quarter earnings fell 40% as generic competition to its depression treatment Lexapro hurt sales, though margins improved. </p> <p> The company forecast fiscal 2013 earnings of $1.20 to $1.35 a share... Tue, 17 Apr 2012 08:55:35 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51861645&headline=forest-laboratories-buys-blood-pressure-drug-bystolic-from-janssen http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51861645&headline=forest-laboratories-buys-blood-pressure-drug-bystolic-from-janssen <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Forest Laboratories Inc. (FRX) acquired the high-blood pressure drug Bystolic from Johnson &amp; Johnson's (JNJ) Janssen Pharmaceutica NV for a one-time cash payment of $357 million, eliminating all future royalties. </p> <p> The companies agreed... Mon, 02 Apr 2012 09:10:09 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51626091&headline=watson-pharma-seeks-fda-approval-of-generic-version-of-bystolic http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51626091&headline=watson-pharma-seeks-fda-approval-of-generic-version-of-bystolic <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Watson Pharmaceuticals Inc. (WPI) has filed an abbreviated new-drug application with the U.S. food and Drug Administration for its generic version of Forest Laboratories Inc.'s (FRX) Bystolic hypertension drug. </p> <p> Forest Labs and Johnson... Wed, 14 Mar 2012 17:10:09 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51624047&headline=teva-receives-fda-approval-for-generic-lexapro-for-adults http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51624047&headline=teva-receives-fda-approval-for-generic-lexapro-for-adults <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) has received U.S. Food and Drug Administration approval to market the first generic version of Forest Laboratories Inc.'s (FRX) Lexapro for adults. </p> <p> The generic drug--escitalopram--is... Wed, 14 Mar 2012 14:58:34 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51623411&headline=forest-labs-janssen-sue-several-drug-makers-over-bystolic http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51623411&headline=forest-labs-janssen-sue-several-drug-makers-over-bystolic <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Forest Laboratories Inc. (FRX) and Johnson &amp; Johnson's (JNJ) Janssen Pharmaceutica NV sued several drug makers over plans to market generic versions of Forest's Bystolic hypertension drug, citing an existing patent. </p> <p> The lawsuit before... Wed, 14 Mar 2012 14:02:40 EDT http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51286795&headline=fda-forest-labs-lung-drug-effective-for-copd-raises-concerns http://www.advfn.com/nyse/StockNews.asp?stocknews=FRX&article=51286795&headline=fda-forest-labs-lung-drug-effective-for-copd-raises-concerns <div class='newsbody'><pre> By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES </pre> <p> WASHINGTON -(Dow Jones)- The Food and Drug Administration said a proposed lung drug that would be marketed by Forest Laboratories Inc. (FRX) to treat chronic obstructive pulmonary disease was effective, but raised... Tue, 21 Feb 2012 11:28:23 EST